Literature DB >> 20388804

YPEL3, a p53-regulated gene that induces cellular senescence.

Kevin D Kelley1, Kelly R Miller, Amber Todd, Amy R Kelley, Rebecca Tuttle, Steven J Berberich.   

Abstract

Cellular senescence, the limited ability of cultured normal cells to divide, can result from cellular damage triggered through oncogene activation (premature senescence) or the loss of telomeres following successive rounds of DNA replication (replicative senescence). Although both processes require a functional p53 signaling pathway, relevant downstream p53 targets have been difficult to identify. Discovery of senescence activators is important because induction of tumor cell senescence may represent a therapeutic approach for the treatment of cancer. In microarray studies in which p53 was reactivated in MCF7 cells, we discovered that Yippee-like-3 (YPEL3), a member of a recently discovered family of putative zinc finger motif coding genes consisting of YPEL1-5, is a p53-regulated gene. YPEL3 expression induced by DNA damage leads to p53 recruitment to a cis-acting DNA response element located near the human YPEL3 promoter. Physiologic induction of YPEL3 results in a substantial decrease in cell viability associated with an increase in cellular senescence. Through the use of RNAi and H-ras induction of cellular senescence, we show that YPEL3 activates cellular senescence downstream of p53. Consistent with its growth suppressive activity, YPEL3 gene expression is repressed in ovarian tumor samples. One mechanism of YPEL3 downregulation in ovarian tumor cell lines seems to be hypermethylation of a CpG island upstream of the YPEL3 promoter. We believe these findings point to YPEL3 being a novel tumor suppressor, which upon induction triggers a permanent growth arrest in human tumor and normal cells. (c)2010 AACR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20388804      PMCID: PMC2862112          DOI: 10.1158/0008-5472.CAN-09-3219

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  p53 has a direct apoptogenic role at the mitochondria.

Authors:  Motohiro Mihara; Susan Erster; Alexander Zaika; Oleksi Petrenko; Thomas Chittenden; Petr Pancoska; Ute M Moll
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

Review 2.  p53 and apoptosis: it's not just in the nucleus anymore.

Authors:  James J Manfredi
Journal:  Mol Cell       Date:  2003-03       Impact factor: 17.970

3.  The Drosophila gene Yippee reveals a novel family of putative zinc binding proteins highly conserved among eukaryotes.

Authors:  K Roxström-Lindquist; I Faye
Journal:  Insect Mol Biol       Date:  2001-02       Impact factor: 3.585

4.  A biomarker that identifies senescent human cells in culture and in aging skin in vivo.

Authors:  G P Dimri; X Lee; G Basile; M Acosta; G Scott; C Roskelley; E E Medrano; M Linskens; I Rubelj; O Pereira-Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1995-09-26       Impact factor: 11.205

5.  Murine fibroblasts lacking p21 undergo senescence and are resistant to transformation by oncogenic Ras.

Authors:  C Pantoja; M Serrano
Journal:  Oncogene       Date:  1999-09-02       Impact factor: 9.867

6.  Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a.

Authors:  M Serrano; A W Lin; M E McCurrach; D Beach; S W Lowe
Journal:  Cell       Date:  1997-03-07       Impact factor: 41.582

7.  Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts.

Authors:  J P Brown; W Wei; J M Sedivy
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

8.  Small unstable apoptotic protein, an apoptosis-associated protein, suppresses proliferation of myeloid cells.

Authors:  Stacey J Baker
Journal:  Cancer Res       Date:  2003-02-01       Impact factor: 12.701

9.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Alterations in gene expression and sensitivity to genotoxic stress following HdmX or Hdm2 knockdown in human tumor cells harboring wild-type p53.

Authors:  Katherine Heminger; Michael Markey; Meldrick Mpagi; Steven J Berberich
Journal:  Aging (Albany NY)       Date:  2009-01       Impact factor: 5.682

View more
  24 in total

Review 1.  Senescence regulation by the p53 protein family.

Authors:  Yingjuan Qian; Xinbin Chen
Journal:  Methods Mol Biol       Date:  2013

2.  Novel senescence associated gene, YPEL3, is repressed by estrogen in ER+ mammary tumor cells and required for tamoxifen-induced cellular senescence.

Authors:  Rebecca Tuttle; Kelly R Miller; J Nicholas Maiorano; Paula M Termuhlen; Yongping Gao; Steven J Berberich
Journal:  Int J Cancer       Date:  2011-08-09       Impact factor: 7.396

3.  RABL6A promotes G1-S phase progression and pancreatic neuroendocrine tumor cell proliferation in an Rb1-dependent manner.

Authors:  Jussara Hagen; Viviane P Muniz; Kelly C Falls; Sara M Reed; Agshin F Taghiyev; Frederick W Quelle; Francoise A Gourronc; Aloysius J Klingelhutz; Heather J Major; Ryan W Askeland; Scott K Sherman; Thomas M O'Dorisio; Andrew M Bellizzi; James R Howe; Benjamin W Darbro; Dawn E Quelle
Journal:  Cancer Res       Date:  2014-10-01       Impact factor: 12.701

4.  p53 dynamics control cell fate.

Authors:  Jeremy E Purvis; Kyle W Karhohs; Caroline Mock; Eric Batchelor; Alexander Loewer; Galit Lahav
Journal:  Science       Date:  2012-06-15       Impact factor: 47.728

Review 5.  Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging.

Authors:  Linda S Steelman; William H Chappell; Stephen L Abrams; Ruth C Kempf; Jacquelyn Long; Piotr Laidler; Sanja Mijatovic; Danijela Maksimovic-Ivanic; Franca Stivala; Maria C Mazzarino; Marco Donia; Paolo Fagone; Graziella Malaponte; Ferdinando Nicoletti; Massimo Libra; Michele Milella; Agostino Tafuri; Antonio Bonati; Jörg Bäsecke; Lucio Cocco; Camilla Evangelisti; Alberto M Martelli; Giuseppe Montalto; Melchiorre Cervello; James A McCubrey
Journal:  Aging (Albany NY)       Date:  2011-03       Impact factor: 5.682

6.  Comprehensive analysis of the expression and prognosis of YPEL family members in clear cell renal cell cancer.

Authors:  Lei Wang; Zhihua Zhang; Xiaochen Zhou; Jian Wu; Zhengdong Hong
Journal:  Oncol Rep       Date:  2022-06-08       Impact factor: 4.136

7.  Identification of a novel endoplasmic reticulum stress response element regulated by XBP1.

Authors:  Michael Misiewicz; Marc-André Déry; Bénédicte Foveau; Julie Jodoin; Derek Ruths; Andréa C LeBlanc
Journal:  J Biol Chem       Date:  2013-06-04       Impact factor: 5.157

8.  The protein p17 signaling pathways in cancer.

Authors:  Klaus Heese
Journal:  Tumour Biol       Date:  2013-07-31

9.  DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control.

Authors:  Xi Chen; Jia Chen; Siting Gan; Huaji Guan; Yuan Zhou; Qi Ouyang; Jue Shi
Journal:  BMC Biol       Date:  2013-06-21       Impact factor: 7.431

10.  MeImmS: Predict Clinical Benefit of Anti-PD-1/PD-L1 Treatments Based on DNA Methylation in Non-small Cell Lung Cancer.

Authors:  Shipeng Shang; Xin Li; Yue Gao; Shuang Guo; Dailin Sun; Hanxiao Zhou; Yue Sun; Peng Wang; Hui Zhi; Jing Bai; Shangwei Ning; Xia Li
Journal:  Front Genet       Date:  2021-05-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.